Future Outlook: Research and Emerging Therapies for Primary Sclerosing Cholangitis

Why Finding a Cure is Challenging
PSC is rare and has a complex, multifactorial origin. Its unpredictable course, silent progression, and diverse presentation make large clinical trials difficult. However, progress is being made on many fronts.
Current Treatments and Limitations
Currently, no FDA-approved medication halts Primary Sclerosing Cholangitis progression. Symptomatic treatments and liver transplants are the primary options. But research is shifting toward disease-modifying therapies.

Primary Sclerosing Cholangitis Market

https://www.coherentmarket...

#PrimarySclerosingCholangitis , #LiverHealth , #PSCawareness ,
#ChronicLiverDisease , #AutoimmuneLiverDisease , #CoherentMarketInsights .